"Dexcom's Stelo: FDA Clears First Over-the-Counter Glucose Monitor"

The FDA has approved the first over-the-counter continuous glucose monitor, the Stelo Glucose Biosensor System, designed for people 18 and older who don't use insulin and are treating diabetes with oral medications, as well as adults who want to track glucose levels. The wearable sensor pairs with a smartphone app to monitor, record, and analyze glucose values every 15 minutes, and can be used for up to 15 days before replacement. However, it is not designed to alert users about low blood sugar levels, and medical decisions should not be made based solely on its output without consulting healthcare providers. Dexcom plans to make the Stelo available this summer, with pricing expected to be competitive.